BRD9 and B-cell chronic lymphocytic leukemia: To explore the role of SF3B1 mutations in alternative splicing of BRD9, we used inducible SF3B1K700E and SF3B1WT overexpression in the CLL cell lines MEC1 and PCL12 (Fig. 3A–C).